Intravitreous Anti-VEGF vs. Prompt Vitrectomy for Vitreous Hemorrhage From Proliferative Diabetic Retinopathy
Phase of Trial: Phase II/III
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Aflibercept (Primary)
- Indications Diabetic retinopathy; Vitreous haemorrhage
- Focus Pharmacokinetics
- 19 May 2017 Planned End Date changed from 1 Oct 2018 to 1 Mar 2020.
- 19 May 2017 Planned primary completion date changed from 1 Apr 2017 to 1 Oct 2018.
- 09 Dec 2016 Status changed from not yet recruiting to recruiting.